Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 0,62 % | -2,47 % | -11,27 % | -29,64 % | -29,35 % | - | - |
| Healthequity Inc. | -1,44 % | 1,48 % | 3,79 % | -11,04 % | -12,18 % | 31,73 % | 14,17 % |
| Omnicell Inc. | 0,70 % | -3,36 % | -15,29 % | -10,00 % | -25,77 % | -45,14 % | -75,80 % |
| Myriad Genetics | 0,00 % | -0,50 % | 10,44 % | -55,82 % | -24,15 % | -81,34 % | -83,77 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




